Additional information
| Active substance | Levocetirizine | 
|---|---|
| Water Retention | Negligible | 
| Hepatotoxicity | Low | 
| Lab Test | Not routinely required | 
| Strength | 5mg | 
| Also known as | Levocetirizine dihydrochloride | 
| Blood pressure | Generally does not affect blood pressure significantly | 
| Trade name | Xyzal | 
| Storage conditions | Store at room temperature, away from excess heat and moisture | 
| Chemical name | (R)-2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetic acid | 
| Formula | C21H25ClN2O3 | 
| Substance class | Antihistamine | 
| Main action | H1 histamine receptor antagonist | 
| Half-life | 6 to 10 hours | 
| Dosage (medical) | 5 mg once daily | 
| Dosage (sports) | Not applicable | 
| Effects | Relief from allergic symptoms such as sneezing, runny nose, itchy or watery eyes, and hives | 
| Side effects | Drowsiness, fatigue, dry mouth, headaches | 
| Use in sports | No specific use in sports | 
| Manufacturer | Cipla Ltd. | 
| Packing | 10 tabs/blister | 
 Januvia 100mg Merckgroup
							Januvia 100mg Merckgroup						 Seretide Disckus (Advair) 500 mcg Glaxosmithkline
							Seretide Disckus (Advair) 500 mcg Glaxosmithkline						


 
			 
			 
			 
			
Reviews
There are no reviews yet.